127 related articles for article (PubMed ID: 38277843)
1. A Lactate-Depleting metal organic framework-based nanocatalyst reinforces intratumoral T cell response to boost anti-PD1 immunotherapy.
Zhou J; Hu Y; Cao Y; Ding S; Zeng L; Zhang Y; Cao M; Duan G; Zhang X; Bian XW; Tian G
J Colloid Interface Sci; 2024 Apr; 660():869-884. PubMed ID: 38277843
[TBL] [Abstract][Full Text] [Related]
2. Catalytically Active Metal-Organic Frameworks Elicit Robust Immune Response to Combination Chemodynamic and Checkpoint Blockade Immunotherapy.
Wang X; Luo J; Wang J; Cao J; Hong Y; Wen Q; Zeng Y; Shi Z; Ma G; Zhang T; Huang P
ACS Appl Mater Interfaces; 2023 Feb; 15(5):6442-6455. PubMed ID: 36700645
[TBL] [Abstract][Full Text] [Related]
3. Two-pronged microenvironmental modulation of metal-oxidase cascade catalysis and metabolic intervention for synergistic tumor immunotherapy.
Song Q; Gao H; Sun S; Li Y; Wu X; Yang J; Wang B; Zhang Y; Wang L
Acta Biomater; 2024 Jan; 173():378-388. PubMed ID: 37925121
[TBL] [Abstract][Full Text] [Related]
4. Dual-Modal Therapeutic Role of the Lactate Oxidase-Embedded Hierarchical Porous Zeolitic Imidazolate Framework as a Nanocatalyst for Effective Tumor Suppression.
Zhou X; Zhao W; Wang M; Zhang S; Li Y; Hu W; Ren L; Luo S; Chen Z
ACS Appl Mater Interfaces; 2020 Jul; 12(29):32278-32288. PubMed ID: 32580547
[TBL] [Abstract][Full Text] [Related]
5. Insights into the Effect of Catalytic Intratumoral Lactate Depletion on Metabolic Reprogramming and Immune Activation for Antitumoral Activity.
Zhao J; Tian Z; Zhao S; Feng D; Guo Z; Wen L; Zhu Y; Xu F; Zhu J; Ma S; Hu J; Jiang T; Qu Y; Chen D; Liu L
Adv Sci (Weinh); 2023 Feb; 10(4):e2204808. PubMed ID: 36479819
[TBL] [Abstract][Full Text] [Related]
6. A Biomimetic Metal-Organic Framework Nanosystem Modulates Immunosuppressive Tumor Microenvironment Metabolism to Amplify Immunotherapy.
Wang H; Wu C; Tong X; Chen S
J Control Release; 2023 Jan; 353():727-737. PubMed ID: 36473607
[TBL] [Abstract][Full Text] [Related]
7. Nanofactory for metabolic and chemodynamic therapy: pro-tumor lactate trapping and anti-tumor ROS transition.
He R; Zang J; Zhao Y; Liu Y; Ruan S; Zheng X; Chong G; Xu D; Yang Y; Yang Y; Zhang T; Gu J; Dong H; Li Y
J Nanobiotechnology; 2021 Dec; 19(1):426. PubMed ID: 34922541
[TBL] [Abstract][Full Text] [Related]
8. Smart biomimetic metal organic frameworks based on ROS-ferroptosis-glycolysis regulation for enhanced tumor chemo-immunotherapy.
Yang J; Ma S; Xu R; Wei Y; Zhang J; Zuo T; Wang Z; Deng H; Yang N; Shen Q
J Control Release; 2021 Jun; 334():21-33. PubMed ID: 33872626
[TBL] [Abstract][Full Text] [Related]
9. Heterostructural Nanoadjuvant CuSe/CoSe
Yang C; Wang M; Chang M; Yuan M; Zhang W; Tan J; Ding B; Ma P; Lin J
J Am Chem Soc; 2023 Apr; 145(13):7205-7217. PubMed ID: 36958054
[TBL] [Abstract][Full Text] [Related]
10. Enhancement of anti-PD-1/PD-L1 immunotherapy for osteosarcoma using an intelligent autophagy-controlling metal organic framework.
Ge YX; Zhang TW; Zhou L; Ding W; Liang HF; Hu ZC; Chen Q; Dong J; Xue FF; Yin XF; Jiang LB
Biomaterials; 2022 Mar; 282():121407. PubMed ID: 35217343
[TBL] [Abstract][Full Text] [Related]
11. Intratumoral Lactate Depletion Based on Injectable Nanoparticles-Hydrogel Composite System Synergizes with Immunotherapy against Postablative Hepatocellular Carcinoma Recurrence.
Chen Y; Bei J; Chen M; Cai W; Zhou Z; Cai M; Huang W; Lin L; Guo Y; Liu M; Huang X; Xiao Z; Xu Z; Zhu K
Adv Healthc Mater; 2024 Mar; 13(6):e2303031. PubMed ID: 37848188
[TBL] [Abstract][Full Text] [Related]
12. Immune-regulating bimetallic metal-organic framework nanoparticles designed for cancer immunotherapy.
Dai Z; Wang Q; Tang J; Wu M; Li H; Yang Y; Zhen X; Yu C
Biomaterials; 2022 Jan; 280():121261. PubMed ID: 34815099
[TBL] [Abstract][Full Text] [Related]
13. Tumor Microenvironment-Activable Manganese-Boosted Catalytic Immunotherapy Combined with PD-1 Checkpoint Blockade.
Zhao Z; Dong S; Liu Y; Wang J; Ba L; Zhang C; Cao X; Wu C; Yang P
ACS Nano; 2022 Dec; 16(12):20400-20418. PubMed ID: 36441901
[TBL] [Abstract][Full Text] [Related]
14. Multicomponent metal-organic framework nanocomposites for tumor-responsive synergistic therapy.
Hur W; Park Y; Seo E; Son SE; Kim S; Seo H; Seong GH
J Colloid Interface Sci; 2023 Sep; 645():663-675. PubMed ID: 37167915
[TBL] [Abstract][Full Text] [Related]
15. 2D Copper(II) Metalated Metal-Organic Framework Nanocomplexes for Dual-enhanced Photodynamic Therapy and Amplified Antitumor Immunity.
Chen Z; Wu Y; Yao Z; Su J; Wang Z; Xia H; Liu S
ACS Appl Mater Interfaces; 2022 Oct; 14(39):44199-44210. PubMed ID: 36165392
[TBL] [Abstract][Full Text] [Related]
16. Self-assembled FeS-based cascade bioreactor with enhanced tumor penetration and synergistic treatments to trigger robust cancer immunotherapy.
Ren H; Yong J; Yang Q; Yang Z; Liu Z; Xu Y; Wang H; Jiang X; Miao W; Li X
Acta Pharm Sin B; 2021 Oct; 11(10):3244-3261. PubMed ID: 34729313
[TBL] [Abstract][Full Text] [Related]
17. Lactate-Responsive Gene Editing to Synergistically Enhance Macrophage-Mediated Cancer Immunotherapy.
Li Y; Wei Y; Huang Y; Qin G; Zhao C; Ren J; Qu X
Small; 2023 Aug; 19(35):e2301519. PubMed ID: 37156740
[TBL] [Abstract][Full Text] [Related]
18. Protein-Delivering Nanocomplexes with Fenton Reaction-Triggered Cargo Release to Boost Cancer Immunotherapy.
Li X; Zhou Q; Japir AAMM; Dutta D; Lu N; Ge Z
ACS Nano; 2022 Sep; 16(9):14982-14999. PubMed ID: 36017992
[TBL] [Abstract][Full Text] [Related]
19. Copper-Coordinated Covalent Organic Framework Produced a Robust Fenton-Like Effect Inducing Immunogenic Cell Death of Tumors.
Li T; Wang D; Meng M; Yang Z; Luo Z; Li Z; Li F; Liu C; Hao K; Pang X; Tian H; Chen X
Macromol Rapid Commun; 2023 Jun; 44(11):e2200929. PubMed ID: 36840703
[TBL] [Abstract][Full Text] [Related]
20. A carbon dot-doped Cu-MOF-based smart nanoplatform for enhanced immune checkpoint blockade therapy and synergistic multimodal cancer therapy.
Su Z; Xu H; Zhang Y; Zhang H; Zhang H; Bao Y; Wu X; Yan R; Tan G; Wang Z; Jin Y
J Mater Chem B; 2023 May; 11(19):4211-4226. PubMed ID: 37114499
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
